Prognostic Importance of 18 F-FDG Positron Emission Tomography in Uterine Cervical Cancer

The aim of this study was to evaluate the prognostic value of F-fluorodeoxyglucose ( F-FDG) positron emission tomography/computed tomography (PET/CT) in the uterine cervix cancer patients. Thirty-two women (mean age: 52.7±12.6) who underwent F-FDG PET/CT for staging of uterine cervix cancer were ret...

Full description

Saved in:
Bibliographic Details
Published in:Molecular imaging and radionuclide therapy Vol. 33; no. 3; p. 167
Main Authors: Soydal, Çiğdem, Baltacıoğlu, Muhammet Halil, Araz, Mine, Demir, Burak, Dursun, Ecenur, Taşkın, Salih, Küçük, Nuriye Özlem, Ortaç, Fırat
Format: Journal Article
Language:English
Published: Turkey 07-10-2024
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The aim of this study was to evaluate the prognostic value of F-fluorodeoxyglucose ( F-FDG) positron emission tomography/computed tomography (PET/CT) in the uterine cervix cancer patients. Thirty-two women (mean age: 52.7±12.6) who underwent F-FDG PET/CT for staging of uterine cervix cancer were retrospectively recruited for the study. Maximum standardized uptake value (SUV ), SUV , metabolic tumor volume (MTV), and total lesion glycolysis (TLG) for primary tumors, lymph nodes, and distant metastases were calculated from F-FDG PET/CT images using the 40% threshold. Patients were divided into groups according to the presence of pelvic and para-aortic lymph node involvement on F-FDG PET/CT images. Life tables and Kaplan-Meier analyses were performed to compare the mean survival times of the different groups. Primary tumor of 27 (84%) patients were F-FDG avid. The median SUV , SUV , MTV, and TLG of the primary tumors were 12.4, 6.1, 13.2 cm and 87.8 g/mL x cm respectively. Pathological uptake was detected in pelvic 14 (44%) patients and in paraaortic lymph nodes in 3 (10%) para-aortic lymph nodes. The median whole-body MTV and TLG were 21.7 cm and 91.1 g/mL x cm . Disease progression was detected in 7 (22%) patients within a median follow-up period of 20.9 (minimum-maximum: 3-82) months. The only significant PET parameter to predict progression-free survival was SUV in the primary tumor (p=0.038). During follow-up period 8 patients died. SUV (p=0.007), MTV (p=0.036), TLG (p=0.001) of primary tumor, presence of pathological uptake on pelvic or paraaortic lymph nodes (p=0.015), whole-body MTV (p=0.047) and whole-body TLG (p=0.001) were found statistically significant PET parameters to predict overall survival. Metabolic parameters of primary tumors derived from F-FDG PET/CT images have prognostic importance for patients with uterine cervical carcinoma. In patients with metastatic disease, higher whole-body MTV and TLG are also associated with poor prognosis.
ISSN:2146-1414